TITLE

PPIs and clopidogrel--Bad combination

AUTHOR(S)
Elliott, William T.
PUB. DATE
July 2009
SOURCE
Travel Medicine Advisor;Jul2009 Pharmacology Watch, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses a May 2009 study presented to the Society for Cardiovascular Angiography and Interventions (SCAI) which urges the discontinuance of a routine combination of clopidogrel (PLAVIN) and proton pump inhibitors (PPI) to patients who underwent coronary stenting. Recovery rate was seen as higher on evaluated patients who took clopidogrel alone than combined with PPI. SCAI believes more research is recommended even as it points out from other studies of similar findings. It further advises that H2 blockers replace PPI in the meanwhile.
ACCESSION #
41994516

 

Related Articles

  • PPIs lower benefit of clopidogrel in stent patients. Pinn, Stephen // British Journal of Hospital Medicine (17508460);Jun2009, Vol. 70 Issue 6, p317 

    The article focuses on the study, conducted by physician Steven Bailey of the Society for Cardiac Angiography and Interventions, which evaluates the effectiveness of proton pump inhibitors (PPIs) to patients who undergone coronary stenting. It found that enzyme inhibitors reduce the levels of...

  • Treatment with clopidogrel and PPI increased risk for adverse outcomes following acute coronary syndrome. Adams, Stacey L.; Harris, Jason; Southall, Jennifer // Hem/Onc Today;4/10/2009, Vol. 10 Issue 7, p29 

    The article discusses a study of the adverse outcomes among patients given the antiplatelet drug clopidogrel with or without proton pump inhibitor (PPI) following hospitalization for acute coronary syndrome (ACS).

  • SCAI: Evidence of interaction between proton pump inhibitors, clopidogrel not sufficient to change practice. Raible, Eric // Cardiology Today;Jan2009, Vol. 12 Issue 1, p18 

    The article reports that conflicting results from two studies of antiplatelet drug clopidogrel and proton pump inhibitors prompted the Society for Cardiovascular Angiography and Interventions (SCAI) to issue a statement clarifying the implications.

  • Pantoprazole: An Update of its Pharmacological Properties and Therapeutic Use in the Management of Acid-Related Disorders. Cheer, S.M.; Prakash, A.; Faulds, D.; Lamb, H.M. // Drugs;2003, Vol. 63 Issue 1, p101 

    Pantoprazole (Protonix) is an irreversible proton pump inhibitor (PPI) that reduces gastric acid secretion. In combination with two antimicrobial agents (most commonly metronidazole, clarithromycin or amoxicillin) for 6-14 days, pantoprazole 40mg twice daily produced Helicobacter pylori...

  • Medication Update.  // McKnight's Long-Term Care News;Mar2012, Vol. 33 Issue 3, p10 

    The article offers medical news briefs on topics including an anticlotting drug trial, use of glucagon-like peptide-1 receptor in weight loss treatment and the role of proton pump inhibitors in increasing the risk of hip fractures in old women.

  • The Use of Proton Pump Inhibitors in Children: A Comprehensive Review. Gibbons, T.E.; Gold, B.D. // Pediatric Drugs;2003, Vol. 5 Issue 1, p25 

    Proton pump inhibitors (PPIs) belong to a group of chemically related compounds whose primary function is the inhibition of acid production in the final common metabolic pathway of gastric parietal cells. PPIs are highly selective and effective in their action and have few short- or long-term...

  • Treatment with clopidogrel, PPI increased risk for adverse outcomes following acute coronary syndrome.  // Cardiology Today;Apr2009, Vol. 12 Issue 4, p13 

    The article discusses a study which found that patients who used proton pump inhibitors (PPI) with clopidogrel had a higher incidence of adverse outcomes following acute coronary syndrome.

  • From the Pharmacy. Acklin, Cara // Saturday Evening Post;Nov/Dec2009, Vol. 281 Issue 6, p79 

    The article discusses several topics of a pharmacological nature. Consumers should avoid ingesting multiple products containing acetaminophen, as too much can lead to liver failure. Additional commentary is provided on using metformin to lower hemoglobin A1c levels, and taking proton pump...

  • Anticoagulation is not always need after coil stent placement.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p46 

    Presents an abstract of the research report entitled `Utilization of the Coronary Balloon-Expandable Coil Stent Without Anticoagulation or Intravascular Ultrasound,' by C.M. Goods, et al published in the May 1996 issue of the `Circulation.'

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics